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Spencer B. King III, MD, MACC, Editor-in-Chief, JACC: Cardiovascular Interventions“I ncredible India” is the current marketingslogan for this vast and diverse land. Thehot news I read this week while in Chennai
was all about the troubled railway system and a major
controversy over blocking normal highway trafﬁc to
allow VIP convoys to freely pass. There is nothing
like trafﬁc to stir emotions. On the interventional
cardiology front, things were different as the emo-
tions stirred seem to be productive and optimistic
ones. A dramatic demonstration of this progress was
the IndiaLIVE conference in Chennai, which has
exploded in size and scope. Dr. Mathew Samuel and
other pioneers of Indian cardiology have made this
conference, like several around the world, a magnet
for the presentation and discussion of issues of prac-
tice. I have participated in this course for a number of
years and was amazed by its growth. I do not know
how many thousands of physicians attended, but
each room was packed to capacity. Physicians
attended from over 20 countries throughout the re-
gion—from the Middle East and Africa to Southeast
Asia, as well as Japan, China, Korea, Europe, and
North America. Live case demonstrations from local
experts and visiting authorities provided the back-
ground for lively discussions. I was impressed by
our Indian colleagues’ lack of reluctance to challenge
each other vigorously. Although discourse was largely
polite, the spicy interchanges to some degree
matched the south Indian cuisine. It reminded me
of the way things once were at the annual American
College of Cardiology and American Heart Association
meetings many years ago. Disagreement openly and
respectfully expressed can go a long way toward
bringing out important teaching points about proce-
dure performance and clinical decision making. The
evidence, and lack thereof, was well understood by
the presenters and audience, and informed judgment
was demonstrated to not always come to the same
conclusions.What were the hot issues? Some that I observed
were related to the epidemic of advanced coronary
artery disease among young Indians. There is a strong
belief that there are genetic predispositions ampliﬁed
by dramatic lifestyle changes. This provides a sub-
strate for signiﬁcant enthusiasm about a technology
with potential long-term hypothetical advantages.
Bioresorbable vascular scaffolds are viewed by some
here as being as good as the latest drug-eluting stents,
with the promise of long-term superiority as the ar-
teries resume somewhat normal function without a
stent remaining. Is all of the evidence in? No! Is the
enthusiasm high? Yes! Are there doubts expressed?
Deﬁnitely yes! All of this is good. First-generation
bioresorbable devices will naturally be very exciting,
and the ability to deliver them in diffusely-diseased
Indian patients was clearly demonstrated. The
“preparation” of the artery to allow implantation of
the devices is called by some the “disruption” of the
artery to make it supple enough. Will this approach
ultimately be benign or not? The diffuse calciﬁed
atherosclerosis, in some cases, prevented even pas-
sage of modern metal stents and required atherec-
tomy in many cases. It was interesting to see that the
decalcifying technology of orbital atherectomy is not
available in India. A technology available in the
United States, but not outside of the United States, is
truly a unique circumstance. At least this gave me a
chance to talk about something technical that they
had not previously experienced. Certainly, the risks
for these young patients are not going to be solved
even by a stent with a perfect result. Research into
secondary prevention remains essential, and appli-
cation of known effective therapies should be applied
to all.
Aside from the rapidly advancing cardiovascular
capabilities in India, their hospitality is unsurpassed.
I was honored to share the Lifetime Achieve-
ment Award with Dr. Alain Cribier, whose seminal
King III J A C C : C A R D I O V A S C U L A R I N T E R V E N T I O N S V O L . 8 , N O . 4 , 2 0 1 5
Editor’s Page A P R I L 2 0 , 2 0 1 5 : 6 4 3 – 4
644contribution of transcatheter aortic valve implanta-
tion has been shared unselﬁshly and extensively
across India. In my acceptance speech, I pointed out
that despite having performed 250,000 percutaneous
interventions and having over 600 cardiac catheteri-
zation laboratories, India is not currently where it
should be in clinical research. Submissions to JACC:
Cardiovascular Interventions by country shows that
India, 1 of the 2 largest countries in the world, ranks
number 12. I predict this will change for several rea-
sons. The clinical activity and expertise of 3,000
interventional cardiologists in India is rapidly ex-
panding. There is increasing interest in investigation,
and organized registries are developing. Unique ap-
proaches to medical care, such as pharmacoinvasive
approaches to ST-segment elevation myocardial
infarction for the vast population that has no access to
primary percutaneous coronary intervention, are be-
ing pioneered by colleagues in south India and could
become a model for many areas of the world. Methodsto perform even high-tech interventions at a fraction
of the cost in Western countries should be widely
studied. Developing device and pharmacological in-
dustries in India have the incentive to invest in
research in the country, and they are beginning to do
that. What are the limitations to expansion of research
from this highly-talented pool of physicians? I was
informed that lack of training in research methods has
been a major defect in the educational system. Much
of the expertise in research and development has been
obtained abroad, but I see this now expanding in India
as well. In the future, the submissions and publica-
tions of important studies from India will, I believe,
far exceed its current position at number 12, and
“Incredible India” will take on a new meaning.
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